These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21419192)

  • 1. Ghrelin in Type 2 diabetes mellitus and metabolic syndrome.
    Ukkola O
    Mol Cell Endocrinol; 2011 Jun; 340(1):26-8. PubMed ID: 21419192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic syndrome and type 2 diabetes.
    Poole R; Byrne CD
    Minerva Endocrinol; 2005 Sep; 30(3):139-59. PubMed ID: 16208305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance.
    Barbagallo M; Dominguez LJ
    Arch Biochem Biophys; 2007 Feb; 458(1):40-7. PubMed ID: 16808892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ghrelin and atherosclerosis.
    Ukkola O
    Curr Opin Lipidol; 2015 Aug; 26(4):288-91. PubMed ID: 26103606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women.
    Nabipour I; Kalantarhormozi M; Larijani B; Assadi M; Sanjdideh Z
    Metabolism; 2010 May; 59(5):742-7. PubMed ID: 19922962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A central role of eNOS in the protective effect of wine against metabolic syndrome.
    Leighton F; Miranda-Rottmann S; Urquiaga I
    Cell Biochem Funct; 2006; 24(4):291-8. PubMed ID: 16170835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ghrelin, obesity and diabetes.
    Wiedmer P; Nogueiras R; Broglio F; D'Alessio D; Tschöp MH
    Nat Clin Pract Endocrinol Metab; 2007 Oct; 3(10):705-12. PubMed ID: 17893689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma ghrelin levels after two high-carbohydrate meals producing different insulin responses in patients with metabolic syndrome.
    Heinonen MV; Karhunen LJ; Chabot ED; Toppinen LK; Juntunen KS; Laaksonen DE; Siloaho M; Liukkonen KH; Herzig KH; Niskanen LK; Mykkänen HM
    Regul Pept; 2007 Feb; 138(2-3):118-25. PubMed ID: 17030069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ghrelin--role in energy homeostasis and glucose metabolism].
    Siejka A; Ruxer J; Loba J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):181-5. PubMed ID: 16232372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants of ghrelin in metabolic disorders.
    Ukkola O
    Peptides; 2011 Nov; 32(11):2319-22. PubMed ID: 21527298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing risk across the spectrum of patients with the metabolic syndrome.
    Rosenson RS
    Am J Cardiol; 2005 Aug; 96(4A):8E-10E. PubMed ID: 16098836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of pravastatin in the pathogenesis of the metabolic syndrome.
    Yamagishi S; Matsui T; Sato T; Takeuchi M
    Med Hypotheses; 2006; 66(3):609-11. PubMed ID: 16171951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.
    Lara-Castro C; Fu Y; Chung BH; Garvey WT
    Curr Opin Lipidol; 2007 Jun; 18(3):263-70. PubMed ID: 17495599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans.
    Lyoussi B; Ragala MA; Mguil M; Chraibi A; Israili ZH
    Clin Exp Hypertens; 2005 May; 27(4):377-94. PubMed ID: 15921074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shift work and metabolic syndrome, diabetes mellitus and ischaemic heart disease.
    Szosland D
    Int J Occup Med Environ Health; 2010; 23(3):287-91. PubMed ID: 20934953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome: psychosocial, neuroendocrine, and classical risk factors in type 2 diabetes.
    Abraham NG; Brunner EJ; Eriksson JW; Robertson RP
    Ann N Y Acad Sci; 2007 Oct; 1113():256-75. PubMed ID: 17513461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular implications of antihyperglycemic therapies for type 2 diabetes.
    Ovalle F
    Clin Ther; 2011 Apr; 33(4):393-407. PubMed ID: 21635987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds.
    Grundy SM
    J Am Coll Cardiol; 2006 Mar; 47(6):1093-100. PubMed ID: 16545636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome, diabetes and cardiovascular events: current controversies and recommendations.
    Zarich SW
    Minerva Cardioangiol; 2006 Apr; 54(2):195-214. PubMed ID: 16778752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.